People: CytRx Corp (CYTR.W)
2.30USD
23 May 2013
$-0.12 (-4.96%)
$2.42
$2.30
$2.30
$2.30
100
63
$5.39
$1.62
Wieland, Douglas
Brief Biography
Dr. Douglas Scott Wieland, Ph.D., is Senior Vice President - Drug Development of CytRx Corporation. He joined CytRx in 2005 as the Vice President, Clinical and Regulatory Affairs and was promoted to the position of Senior Vice President, Drug Development in December 2008. Prior to that, he served in senior level positions in the areas of Drug Development, Clinical and Regulatory Affairs at various biotech firms. He spent five years at NeoTherapeutics, Inc. serving as the Director of Product Development and was later promoted to Vice President of Product Development. From 1990 to 1997, he served as Director of Regulatory Affairs at CoCensys, Inc. Dr. Wieland has a Ph.D. in Biopsychology and an M.A. in Psychology from the University of Arizona. He has an MBA from Webster University. Dr. Wieland received his B.S. in Physiological Psychology from the University of California, Santa Barbara.
Basic Compensation
| Total Annual Compensation, USD | Long-Term Incentive Plans, USD | All Other, USD | Fiscal Year Total, USD |
|---|---|---|---|
| 405,000 | -- | 131,000 | 536,000 |
Options Compensation
| Quantity | Market Value | |
|---|---|---|
| Excercisable | -- | -- |
| Unexercisable | -- | -- |
| Excercised | -- | -- |
| Name | Fiscal Year Total |
|---|---|
Max Link |
-- |
Steven Kriegsman |
1,518,700 |
Marvin Selter |
-- |
John Caloz |
546,000 |
Daniel Levitt |
786,900 |
Douglas Wieland |
536,000 |

